Oxford considers the variant top priority for vaccine developers, and AstraZeneca has targeted the development of new vaccines against variants by the autumn. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.